{"schema_version":"1","generated_at":"2026-11-06T08:48:56.195Z","data_as_of":null,"url":"https://www.findmykol.com/kol/nicoletta-machin","json_url":"https://www.findmykol.com/kol/nicoletta-machin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"nicoletta-machin","name":"Nicoletta Machin","credential":"DO","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Pittsburgh","institution_url":"https://www.findmykol.com/institution/university-of-pittsburgh","city":"Pittsburgh","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1619395464","orcid":"0000-0003-2776-8987","openalex":"A5081863090"},"summary":"Nicoletta Machin is an Oncology physician affiliated with University of Pittsburgh. OpenAlex indexes 37 publications with 386 citations (h-index 9); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":37,"cited_by_count":386,"h_index":9,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07083583","title":"Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders","status":"RECRUITING","role":"Overall official","sponsor":"Nicoletta C Machin","source_url":"https://clinicaltrials.gov/study/NCT07083583","trial_url":"https://www.findmykol.com/trial/NCT07083583"},{"nct":"NCT04344860","title":"Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"Nicoletta C Machin","source_url":"https://clinicaltrials.gov/study/NCT04344860","trial_url":"https://www.findmykol.com/trial/NCT04344860"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":12,"shown":3,"withheld":9,"rows":[{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":2332.74,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619395464"},{"payer":"Diagnostica Stago SAS","program_year":2025,"amount_usd":466,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619395464"},{"payer":"Stryker Corporation","program_year":2025,"amount_usd":55.07,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619395464"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1619395464","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Blood & clotting","share_pct":87.9,"classes_total":3,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":51.7,"drugs":[{"name":"Fondaparinux Sodium","share_pct":48.3},{"name":"Eliquis","share_pct":26.7},{"name":"Xarelto","share_pct":25}],"max_beneficiaries":null},{"class":"Vitamin K antagonist","setting":"prescribed","share_pct":21.6,"drugs":[{"name":"Warfarin Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":12.1,"classes_total":1,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":12.1,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":37,"shown":5,"withheld":32,"matched_by":"OpenAlex author record","recent":[{"title":"Risk of Postpartum Hemorrhage in Women With Von Willebrand Disease: A Real‐World Data Analysis","year":2026,"journal":"Haemophilia","source_url":"https://doi.org/10.1111/hae.70400","status":"verified"},{"title":"OC 63.2 Bleeding Disorder of Unknown Cause (BDUC): A National Practice Survey of US Hemophilia Treatment Centers","year":2026,"journal":"Research and Practice in Thrombosis and Haemostasis","source_url":"https://doi.org/10.1016/j.rpth.2026.103775","status":"verified"},{"title":"PB3420 Qualitative Study Exploring the Lived Experiences of Adolescents and Adults with von Willebrand Disease Treated with VGA039 and Their Families in the VIVID-3 Phase 1/2 Clinical Study","year":2026,"journal":"Research and Practice in Thrombosis and Haemostasis","source_url":"https://doi.org/10.1016/j.rpth.2026.106039","status":"verified"},{"title":"OC 32.3 Subcutaneous Four-Week Dosing of the Novel Protein S Antibody VGA039 Demonstrates Safety and Clinically Meaningful Bleed Reduction in Patients with Von Willebrand Disease: Phase 1/2 Multi-Dose Study Results","year":2026,"journal":"Research and Practice in Thrombosis and Haemostasis","source_url":"https://doi.org/10.1016/j.rpth.2026.103621","status":"verified"},{"title":"PB1496 Single center chart review of Hemophilia A patients with prior inhibitors treated with recombinant Factor VIII Efanesoctocog alfa to assess inhibitor recurrence","year":2026,"journal":"Research and Practice in Thrombosis and Haemostasis","source_url":"https://doi.org/10.1016/j.rpth.2026.104358","status":"verified"}],"source":"works"},"contact":{"address_1":"5230 CENTRE AVE","city":"Pittsburgh","state":"PA","zip":"152321304","phone":"412-623-2465","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1619395464","source":"identity"},"similar":[{"name":"Norman Wolmark","slug":"norman-wolmark","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/norman-wolmark","json_url":"https://www.findmykol.com/kol/norman-wolmark/profile.json"},{"name":"Sally Wenzel","slug":"sally-wenzel","institution":"University of Pittsburgh","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/sally-wenzel","json_url":"https://www.findmykol.com/kol/sally-wenzel/profile.json"},{"name":"Mary Phillips","slug":"mary-phillips","institution":"University of Pittsburgh","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/mary-phillips","json_url":"https://www.findmykol.com/kol/mary-phillips/profile.json"},{"name":"Udai Kammula","slug":"udai-kammula","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/udai-kammula","json_url":"https://www.findmykol.com/kol/udai-kammula/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":9,"publications":32}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-07-27","provider_certified":"2021-07-27","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}